Nuwellis, Inc.

Nuwellis, Inc.

$0.26
-0.01 (-5.41%)
NASDAQ
USD, US
Medical - Devices

52 Week Range

0.13-3.83

Beta

0.3

Market Cap

$4.68M

Last Dividend

0

PE (TTM)

-0.09

Dividend Yield (TTM)

0

Price Chart

Industry

Medical - Devices

Sector

Healthcare

CEO

Mr. Nestor Jaramillo Jr.

Full-Time Employees

59

IPO Date

2012-02-16

Description

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Phone

952 345 4200

Address

12988 Valley View Road, Eden Prairie, MN, 55344, US

CIK

0001506492